New Targets for Coronavirus Antiviral Drugs Identified in Recent Study

Just now November 3, 2026 1 min read 📰 Phys.org

📋 Key Takeaway

A study co-led by a University of California, Riverside scientist has identified new antiviral drug targets for coronavirus, potentially offering treatments that are less susceptible to viral evolution. This research could have implications for global health, including Iran's ongoing efforts to manage COVID-19. The findings may enhance Iran's pharmaceutical capabilities in combating the virus.

A study co-led by a University of California, Riverside, biomedical scientist has identified new targets for coronavirus antiviral drugs, including treatments that may be less vulnerable to the rapid evolution of these viruses.